TMTC4 was higher expression in LGG, glioblastoma (GBM), bile duct cancer (CHOL), COAD, large B‐cell lymphoma (DLBC), prostate cancer (PRAD), rectal cancer (READ), and THYM than in normal tissue (Figure S10D). Here, TMTC4 is linked to prostate adenocarcinoma.